IXYS Corporation (NASDAQ: IXYS)

Rowley Law PLLC is investigating potential claims against IXYS Corporation (NASDAQ: IXYS) and its board of directors for breach of fiduciary duty concerning the proposed acquisition of the company by Littelfuse, Inc. IXYS shareholders will receive either $23.00 in cash or 0.1265 shares of Littelfuse common stock per share of IXYS, for a total […]

IXYS Corporation (NASDAQ: IXYS)2017-10-30T16:24:47+00:00

Kite Pharma, Inc. (NASDAQ: KITE)

Rowley Law PLLC is investigating potential claims against Kite Pharma, Inc. (NASDAQ: KITE) and its board of directors for breach of fiduciary duty concerning the proposed acquisition of the company by Gilead Sciences, Inc. for $180.00 per share in cash. The transaction is valued at approximately $11.9 billion and is expected to close in […]

Kite Pharma, Inc. (NASDAQ: KITE)2017-10-30T16:24:56+00:00

Dimension Therapeutics, Inc. (NASDAQ: DMTX)

Rowley Law PLLC is investigating potential claims against Dimension Therapeutics, Inc. (NASDAQ: DMTX) and its board of directors for breach of fiduciary duty concerning the proposed acquisition of the company by REGENXBIO Inc. in an all-stock transaction valued at approximately $85.4 million. The transaction is expected to close by the end of 2017.

If you […]

Dimension Therapeutics, Inc. (NASDAQ: DMTX)2017-10-30T16:25:02+00:00

Calpine Corporation (NYSE: CPN)

Rowley Law PLLC is investigating potential claims against Calpine Corporation (NYSE: CPN) and its board of directors for breach of fiduciary duty concerning the proposed acquisition of the company by Energy Capital Partners and a consortium of investors for $15.25 per share in cash. The transaction is valued at approximately $5.6 billion.

If you are […]

Calpine Corporation (NYSE: CPN)2017-10-30T16:25:11+00:00

Sunshine Bancorp, Inc. (NASDAQ: SBCP)

Rowley Law PLLC is investigating potential claims against Sunshine Bancorp, Inc. (NASDAQ: SBCP) and its board of directors for breach of fiduciary duty concerning the proposed acquisition of the company by CenterState Bank, NA. The all-stock transaction is valued at approximately $176.7 million and is expected to close in the first quarter of 2018.

If […]

Sunshine Bancorp, Inc. (NASDAQ: SBCP)2017-10-16T18:12:23+00:00

Western Refining Logistics (NYSE: WNRL)

Rowley Law PLLC is investigating potential claims against Western Refining Logistics (NYSE: WNRL) and its board of directors for breach of fiduciary duty concerning the proposed acquisition of the company by Andeavor Logistics. Western Refining Logistics public unitholders will receive 0.5233 units of Andeavor Logistics. The transaction is valued at approximately $1.8 billion (including […]

Western Refining Logistics (NYSE: WNRL)2017-10-16T18:12:39+00:00

Starwood Waypoint Homes (NYSE: SFR)

Rowley Law PLLC is investigating potential claims against Starwood Waypoint Homes (NYSE: SFR) and its board of directors for breach of fiduciary duty concerning the proposed merger of the company with Invitation Homes. Starwood Waypoint Homes shareholders will receive 1.614 shares of Invitation Homes stock in the merger and will own approximately 41% of […]

Starwood Waypoint Homes (NYSE: SFR)2017-10-16T18:12:50+00:00

Plaza Bancorp (OTC Pink: PLZZ)

Rowley Law PLLC is investigating potential claims against Plaza Bancorp (OTC Pink: PLZZ) and its board of directors for breach of fiduciary duty concerning the proposed acquisition of the company by Pacific Premier Bancorp, Inc. in an all-stock transaction valued at approximately $226 million. The transaction is expected to close in the fourth quarter […]

Plaza Bancorp (OTC Pink: PLZZ)2017-10-16T18:13:02+00:00

NxStage Medical, Inc. (NASDAQ: NXTM)

Rowley Law PLLC is investigating potential claims against NxStage Medical, Inc. (NASDAQ: NXTM) and its board of directors for breach of fiduciary duty concerning the proposed acquisition of the company by Fresenius Medical Care for $30.00 per share in cash. The transaction is valued at approximately $2 billion and is expected to close in […]

NxStage Medical, Inc. (NASDAQ: NXTM)2017-10-16T18:13:13+00:00

PharMerica Corporation (NYSE: PMC)

Rowley Law PLLC is investigating potential claims against PharMerica Corporation (NYSE: PMC) and its board of directors for breach of fiduciary duty concerning the proposed acquisition of the company by KKR, and Walgreens Boots Alliance, Inc. as a minority investor, for $29.25 per share in cash. The transaction is valued at approximately $1.4 billion […]

PharMerica Corporation (NYSE: PMC)2017-10-06T17:04:29+00:00
Go to Top